infertility
Conditions
Interventions
Group A:Follicular stage HMG combined with progestin
Group B:HMG + progestin + letrozole
Sponsors
Shanghai Ninth People’s Hospital, Shanghai Jiaotong University School of Medicine
Eligibility
Sex/Gender
Female
Age
20 Years to 40 Years
Inclusion criteria
Inclusion criteria: The medical records of Chinese women with polycystic ovarian syndrome undergoing IVF- ET cycles and reaching the oocyte pick-up stage at Reproductive Medical Center, Shanghai Ninth People's Hospital, Shanghai Jiaotong University, between January 2018 and January 2019 were reviewed. All patients should meet the PCOS definition specified in the 1990 National Institute of Health-National institute of Child Health and Human Development conference or in 2003 Rotterdam conference by the European Society for Human Reproduction and Embryology (ESHRE) and the American Society for Reproductive Medicine (ASRM). Aged 20-38 years, FSH less than 10IU/L, BMI<25.
Exclusion criteria
Exclusion criteria: male factor, ovarian failure, severe endometrosis, acute genital tract infection and other systemtic diseases.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| the number of oocyte retrieved;LH value; | — |
Secondary
| Measure | Time frame |
|---|---|
| HMG consumption per oocyte retrieval;number of viable embryos; | — |
Contacts
Public ContactYanping Kuang
Shanghai Nineth People's Hospital
Outcome results
None listed